Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial

2019178 citationsJournal Articlehybrid Open Access

Authors

Walter Taylor · Mahidol University

Kamala Thriemer · Charles Darwin University

Lorenz von Seidlein · Mahidol University

Prayoon Yuentrakul · Mahidol University

Thanawat Assawariyathipat · Mahidol Oxford Tropical Medicine Research Unit

Ashenafi Assefa · Ethiopian Public Health Institute

Sarah Auburn

Abstract

UK Department for International Development, UK Medical Research Council, UK National Institute for Health Research, and the Wellcome Trust through the Joint Global Health Trials Scheme (MR/K007424/1) and the Bill & Melinda Gates Foundation (OPP1054404).

Topics & Keywords

Malaria Research and Control Pharmacological Effects and Toxicity Studies Drug-Induced Hepatotoxicity and Protection

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Lancet

Volume 394, Issue 10202, pp. 929-938

DOI: 10.1016/s0140-6736(19)31285-1

Field-Weighted Citation Impact: 19.95